FDAAA’s First Advertising Victim Is MedImmune’s FluMist
This article was originally published in The Pink Sheet Daily
Executive Summary
“Reminder” newspaper ad actually makes claims and lacks toll-free number for reporting side effects, FDA says.
You may also be interested in...
Toll-Free Number For Adverse Event Reporting Due On Labels By Mid-2009
Industry will have an extra six months - until July 1, 2009 - to comply with a requirement that drugs be dispensed with information on a toll-free number for reporting adverse events, according to a final rule on the topic issued by FDA Oct. 28
Rozerem DTC Ad Suggests Insomnia Drug Is Indicated In Children – FDA
Agency issues an "untitled" letter to Takeda citing the 10-second TV spot.
PhRMA DTC Principles Call For End Of Reminder Ads
Independent review panel will be established to handle complaints about pharmaceutical advertising.